Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Fischer Medical Ventures Ltd ( (IN:FISCHER) ) has shared an update.
Fischer Medical Ventures Limited has announced the appointment of Mr. Chan Sing En as an Additional Non-Executive Independent Director, effective October 28, 2025, for a five-year term, subject to shareholder approval. Mr. Chan brings over three decades of experience in investment, private equity, and corporate finance, enhancing the company’s strategic positioning and operational capabilities. Additionally, the board has recommended the appointment of Tan Sri Dato’ Dr. Syed Jalaludin as an Independent Director, further strengthening the company’s leadership team.
More about Fischer Medical Ventures Ltd
Fischer Medical Ventures Limited operates in the medical industry, focusing on investments and strategic partnerships to drive growth and value creation. The company is involved in private equity, corporate finance, and operational turnarounds, with a market focus on Southeast Asia and Australia.
Average Trading Volume: 52,814
Technical Sentiment Signal: Strong Buy
Current Market Cap: 67.51B INR
See more data about FISCHER stock on TipRanks’ Stock Analysis page.